medigraphic.com
Colegio de Medicina Interna de México.

2018, Number 3

<< Back Next >>

Med Int Mex 2018; 34 (3)

Obstructive sleep apnea assessed with Epworth and Stop-Bang questionnaires and its relationship with metabolic syndrome

Vicente-Herrero, María Teófila; Capdevila-García L, Bellido-Cambrón MC, Ramírez-Íñiguez de la Torre MV, Lladosa-Marco S

Language: Spanish
References: 29
Page: 373-380
PDF size: 411.66 Kb.


ABSTRACT

Objective: Metabolic syndrome includes a group of conditions involving an increased risk of developing cardiovascular disease and type 2 diabetes. Its growing prevalence makes it a preventive priority in the scientific community.
Objetive: To quantify sleep hours and to know the risk of sleep apnoea detected and the relationship with the metabolic syndrome in workers.
Material and Method: An epidemiological cross-sectional study was done in 1110 workers in the Spanish Public Administration during periodic health surveillance from January to December 2015. The risk of presenting nocturnal apnoea was assessed using Epworth and Stop-Bang questionnaires, and their influence on metabolic syndrome with International Diabetes Federation (IDF) and Adult Treatment Panel III (ATP III) criteria.
Results: The number of hours of sleep is not related to the greater presence of metabolic syndrome in the working population. The detection of obstructive sleep apnoea-hypopnea syndrome with Epworth and Stop-Bang questionnaires showed significant relationship with metabolic syndrome with IDF and ATP III criteria.
Conclusions: The highest risk of obstructive sleep apnoea-hypopnea syndrome assessed shows statistic relation to a higher prevalence of metabolic syndrome.


REFERENCES

  1. Meigs JB. Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated risk factors. Am J Epidemiol 2000;152(10):908-11.

  2. Reavan GM. Role of insulin resistance in human disease. Diabetes 1988;37(12):1595-607.

  3. Laaksonen DE, Lakka HM, Niskanen LK, et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156(11):1070-7.

  4. Koren-Morang N, Goldbourt U, Tanne D. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack. A prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 2005;36(7):1366-71.

  5. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):16405.

  6. Simons RK, Alberti KG, Gale EA, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia 2010;53(4):600-5.

  7. Lawlor DA, Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study. Diabetologia 2006;49(1):41-8.

  8. Novoa MT, Fernández AA, Perez MT, et al.Metabolic syndrome and its components in patients with sleep apnea síndrome. An Sist Sanit Navar 2011 Sep-Dec;34(3):363-72.

  9. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apneahypopnea and related clinical features in a populationbased sample of subjects aged 30-70 yr. Am J Respir Crit Care Med 2001 Mar;163 (3 Pt 1):685-9.

  10. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 2015 Aug;7(8):1311-22.

  11. Yang EH, Hla KM, McHorney CA, et al. Sleep apnea and quality of life. Sleep 2000 Jun 15;23(4):535-41.

  12. Anker SD, von Haehling S, Germany R. Sleep-disordered breathing and cardiovascular disease. Indian Heart J 2016 Apr; 68 Suppl 1:S69-76.

  13. Ferrer M, Vilagut G, Monasterio C, et al. Medida del impacto de los trastornos del sueño: las versiones españolas del cuestionario del impacto funcional del sueño y de la escala de somnolencia de Epworth. Med Clin (Barc) 1999 Sep 11;113(7):250-5.

  14. Borsini E, Salvado A, Bosio M, et al. Utilidad de los componentes del cuestionario Stop-Bang para identificar pacientes con apneas del sueño. Rev Am Med Respir Dic. 2014;14(4): CABA.

  15. Ley 31/1995, de 8 de noviembre, de Prevención de Riesgos Laborales. Boletín Oficial del Estado nº 269, de 10 de noviembre de 1995;32590-611.

  16. Chung F, Yang Y, Brown R, et al. Alternative scoring models of STOP-bang questionnaire improve specificity to detect undiagnosed obstructive sleep apnea. J Clin Sleep Med 2014 Sep 15;10(9):951-8.

  17. Chiner E, Arriero JM, Signes-Costa J, et al. Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome. Arch Bronconeumol 1999 Oct;35(9):422-7.

  18. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-92.

  19. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Consultado el 15 de febrero de 2014. Disponible en: [http://www. idf.org/metabolic-syndrome].

  20. Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res 2007 Mar;4(1):32-8.

  21. Kocełak P, Chudek J, Olszanecka-Glinianowicz M. Prevalence of metabolic syndrome and insulin resistance in overweight and obese women according to the different diagnostic criteria. Minerva Endocrinol 2012 Sep;37(3):247-54.

  22. Grandner MA, Chakravorty S, Perlis ML, et al. Habitual sleep duration associated with self-reported and objectively determined cardiometabolic risk factors. Sleep Med 2014 Jan;15(1):42-50.

  23. Burns N. An integrative review of screening for obstructive sleep apnea in commercial vehicle drivers. Workplace Health Saf 2014 Mar;62(3):114-20.

  24. Nagappa M, Liao P, Wong J, et al. Validation of the STOPBang Questionnaire as a screening tool for obstructive sleep apnea among different populations: a systematic review and meta-analysis. PLoS One 2015;10(12):e0143697.

  25. Baldini M, Chiapella MN, Fernández MA, et al. Stop-Bang, a useful and easy tool for the screening of obstructive sleep apnea. Medicina (B Aires) 2017;77(3):191-5.

  26. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991 Dec;14(6):540-5.

  27. Smith SS, Oei TP, Douglas JA, et al. Confirmatory factor analysis of the Epworth Sleepiness Scale (ESS) in patients with obstructive sleep apnoea. Sleep Med 2008 Oct;9(7):739-44.

  28. Sil A, Barr G. Assessment of predictive ability of Epworth scoring in screening of patients with sleep apnoea. J Laryngol Otol 2012 Apr;126(4):372-9.

  29. Ramírez Íñiguez de la Torre MV. Determinación del Riesgo Cardiovascular en una población laboral aparentemente sana. Relación con Variables Sociodemográficas y Laborales. UIB. Palma de Mallorca: Universidad Islas Baleares; febrero 2017.




2020     |     www.medigraphic.com